cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Collegium Pharmaceutical Inc
5 own
17 watching
Current Price
$34.5
$0.35
(1.02%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,254.61M
52-Week High
52-Week High
40.95000
52-Week Low
52-Week Low
20.83000
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
7.3718
iconMarket Capitalization1,254.61M
icon52-Week High40.95000
icon52-Week Low20.83000
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio7.3718
What does the Collegium Pharmaceutical Inc do?
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. It offers Xtampza, an oral formulation of oxycodone, for the management of pain. The company also develops Onsolis, a transmucosal immediate-release fentanyl film indicated for the management of breakthrough pain in cancer patients 18 years of age and older. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-196, a morphine formulation to treat pain; and COL-171, a methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.
Read More
How much money does Collegium Pharmaceutical Inc make?
News & Events about Collegium Pharmaceutical Inc.
Globe Newswire
1 year ago
Highlights 2022 environmental, social and governance achievementsSTOUGHTON, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced the release of its inaugural Environmental, Social and ...
Globe Newswire
1 year ago
STOUGHTON, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the pricing of its offering of $210,000,000 aggregate principal amount of 2.875% convertible senior notes due 2029 (the notes) in a private offering to qualified institutional buyers ...
Globe Newswire
1 year ago
Product Revenues, Net Expected in the Range of $565.0 Million to $580.0 Million Adjusted Operating Expenses* Expected in the Range of $135.0 Million to $145.0 Million Adjusted EBITDA* Expected in the Range of $355.0 Million to $370.0 Million $100 Million Share Repurchase Program Authorized by the ...
Globe Newswire
1 year ago
Mike Heffernan appointed Chairman of NMD Pharmas Board of Directors Brings 30 years of experience building private and public development-stage and commercial biopharmaceutical companies and has overseen several successful IPOs and trade sales Aarhus, Denmark, 3 January 2023 NMD Pharma A/S, a ...
Globe Newswire
1 year ago
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expirySTOUGHTON, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that the Federal Circuit has upheld the judgment of ...
Frequently Asked Questions
Frequently Asked Questions
What is Collegium Pharmaceutical Inc share price today?
plus_minus_icon
Can Indians buy Collegium Pharmaceutical Inc shares?
plus_minus_icon
How can I buy Collegium Pharmaceutical Inc shares from India?
plus_minus_icon
Can Fractional shares of Collegium Pharmaceutical Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Collegium Pharmaceutical Inc stocks?
plus_minus_icon
What is today’s traded volume of Collegium Pharmaceutical Inc?
plus_minus_icon
What is today’s market capitalisation of Collegium Pharmaceutical Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Collegium Pharmaceutical Inc?
plus_minus_icon
What percentage is Collegium Pharmaceutical Inc down from its 52-Week High?
plus_minus_icon
What percentage is Collegium Pharmaceutical Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$34.5
$0.35
(1.02%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00